Sand Grove Capital Management LLP Abcam PLC Transaction History

Sand Grove Capital Management LLP

  • $248 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$21.54 - $24.41 $49.1 Million - $55.6 Million
2,278,464 New
2,278,464 $51.6 Million

Others Institutions Holding ABCM

# of Institutions
4
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Abcam plc

ABCM Quotes by TradingView
  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Sand Grove Capital Management LLP Portfolio

Follow Sand Grove Capital Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sand Grove Capital Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sand Grove Capital Management LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email